Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PCR-Based Diagnostics Move Out of the Lab and into the Field

By LabMedica International staff writers
Posted on 10 Sep 2014
Researchers in New Zealand have revealed a novel battery-powered, handheld quantitative PCR analyzer for use under field conditions to detect minute levels of viral or bacterial DNA.

Investigators at the University of Otago (New Zealand) recently described a robust unit weighing about the same as a typical laptop computer and able to fit on the palm of the hand. More...
The so-called "Freedom4" instrument boasts a six-hour battery life and can be attached by cable to a laptop computer, or connected wirelessly to a smart phone or tablet computer that is running a custom software application able to analyze and interpret the test results.

“We are immensely proud that we have created this brilliant device; there is currently no other system in the world that compares in terms of the analytical power we have achieved at this level of mobility and ease of use, said Dr. Jo-Ann Stanton, senior research fellow in the department of anatomy at the University of Otago. “This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analyzing samples from various locations, make their diagnoses and treat infected animals—all in one trip.”

A prototype Freedom4 instrument was evaluated by the New Zealand Institute of Environmental and Scientific Research (Wellington). Results obtained by assays for toxin-producing E. coli, and several gastrointestinal and respiratory viruses—including the H1N1 serotype influenza virus—were said to correlate well with those from much larger laboratory-based DNA analysis systems.

Related Links:
University of Otago
New Zealand Institute of Environmental and Scientific Research



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
Gel Cards
DG Gel Cards
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.